Similar Articles
Biologics in juvenile idiopathic arthritis-main advantages and major challenges: A narrative review
Amra ADROVIC, Mehmet YILDIZ, Oya KÖKER, Sezgin ŞAHİN, Kenan BARUT, Özgür KASAPÇOPUR
DOI: 10.46497/ArchRheumatol.2021.7953
Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism mediating the suppressing of uveitis attacks
Murat KARKUCAK, Mehmet KOLA, Ahmet KALKIŞIM, Erhan ÇAPKIN, Ahmet AYAR, Adem TÜRK
DOI: 10.46497/ArchRheumatol.2021.7806
Experience of therapeutic plasma exchange in rheumatic diseases: Albumin may be a suitable substitute for plasma
Zhiqian Bai, Yu Chen, Lingli Dong
DOI: 10.46497/ArchRheumatol.2021.8447
Patient perspectives on biological treatments for inflammatory arthritis: A multi-center study in Korea
In Ah Choi, Ji Hyoun Kim, Sung Hae Chang, Ran Song, You-Jung Ha, Hye Won Kim, Jeong Seok Lee, Byoongyong Choi, Yoon-Jeong Oh, Ki Won Moon
DOI: 10.46497/ArchRheumatol.2021.8524
Vaccines in adults with autoimmune inflammatory rheumatic disease: What are the knowledge and attitudes of physicians?
Suade Özlem Badak
DOI: 10.46497/ArchRheumatol.2022.9303
Association of tumor necrosis factor-alpha promoter region gene polymorphism at positions -308G/A, -857C/T, and -863C/A with etanercept response in Iraqi rheumatoid arthritis patients
Samer Mohammed, Munaf Zalzala, Faiq Gorial
DOI: 10.46497/ArchRheumatol.2022.9272
Clinical course and prognostic factors of COVID-19 infection in patients with chronic inflammatory-rheumatic disease: A retrospective, case-control study
Kemal Nas, Ertuğrul Güçlü, Yaşar Keskin, Gamze Dilek, Mehtap Kalçık Unan, Nurselin Can, İbrahim Tekeoğlu, Ayhan Kamanlı
DOI: 10.46497/ArchRheumatol.2023.9289
How do COVID-19 vaccines affect rheumatic diseases?
Lale Altan, Salim Mısırcı, İlker Yağcı, Meltem Karacaatlı, Feyza Ünlü Özkan, Altuğ Güner, İlknur Aktaş
DOI: 10.46497/ArchRheumatol.2023.9530
Rituximab for rheumatoid arthritis-related interstitial lung disease: A systematic review and meta-analysis
Tarun Krishna Boppana, Saurabh Mittal, Karan Madan, Anant Mohan, Vijay Hadda, Randeep Guleria
DOI: 10.46497/ArchRheumatol.2023.10199
Real-life data on the comorbidities in spondyloarthritis from our multicenter nationwide registry: BioStar
H. Fatih Çay, Meltem Alkan Melikoğlu, Fatma Gül Yurdakul, Hatice Bodur, Şebnem Ataman, Erhan Çapkın, Gülcan Gürer, İlhan Sezer, M. Tuncay Duruöz, Aylin Rezvani, İlker Yağcı, Feride Göğüş, Ayhan Kamanli, Remzi Çevik, Özgür Akgül
DOI: 10.46497/ArchRheumatol.2023.9793
Epidemiological characteristics of hepatitis B and C in patients with inflammatory arthritis: Implications from treasure database
Emine Duygu Ersözlü, Mustafa Ekici, Belkis Nihan Coşkun, Suade Özlem Badak, Emre Bilgin, Umut Kalyoncu, Burcu Yağız, Yavuz Pehlivan, Orhan Küçükşahin, Abdulsamet Erden, Dilek Solmaz, Pamir Atagündüz, Gezmiş Kimyon, Cemal Beş, Seda Çolak, Rıdvan Mercan, Timuçin Kaşifoğlu, Hakan Emmungil, Nilüfer Alpay Kanıtez, Aşkın Ateş, Süleyman Serdar Koca, Sedat Kiraz, İhsan Ertenli
DOI: 10.46497/ArchRheumatol.2023.9504
Analysis of treatment outcomes in patients with antineutrophil cytoplasmic antibody-associated vasculitis on rituximab therapy
Tsvetelina Yoneva, Yana Zdravkova, Georgi Kotov, Ekaterina Ivanova Todorova, Georgi Vasilev, Rasho Rashkov, Ivan Sheytanov
DOI: 10.46497/ArchRheumatol.2023.9556
Efficacy of coronavirus disease 2019 vaccines in patients with rheumatic diseases
Fatih Taştekin, Meltem Taşbakan, Candan Çiçek, Mehmet Soylu, Figen Yargucu Zihni
DOI: 10.46497/ArchRheumatol.2023.9676
Risk of tuberculosis in children with rheumatologic diseases treated with biological agents: A cross-sectional cohort study
Nuri Bayram, Özge Altuğ Gücenmez, Balahan Makay, Elif Kıymet, Elif Böncüoğlu, Şahika Şahinkaya, Yelda Sorguç, Aybüke Akaslan Kara, Kamile Ötiken Arıkan, İlker Devrim
DOI: 10.46497/ArchRheumatol.2023.9900
Three-dimensional kinematics of the trunk, pelvis, hip, and knee during the single-leg squat and hip torque in subjects with isolated patellofemoral osteoarthritis compared to individually matched controls: Preliminary results
Cristiano Carvalho, Fábio Viadanna Serrão, Adalberto Felipe Martinez, Paula Regina Mendes Da Silva Serrão
DOI: 10.46497/ArchRheumatol.2024.9814
Biological treatment in elderly and young patients with ankylosing spondylitis: TURKBIO real-life data results
Sadettin Uslu, Semih Gülle, Özkan Urak, Gerçek Şen, Ediz Dalkılıç, Soner Şenel, Servet Akar, Nevsun İnanç, Ayşe Cefle, Aydan Köken Avşar, Servet Yolbaş, Sema Yılmaz, Özgül Soysal Gündüz, İsmail Sarı, Merih Birlik, Nurullah Akkoç, Fatoş Önen
DOI: 10.46497/ArchRheumatol.2024.10391
COVID-19 vaccination rates and factors affecting vaccination in children with rheumatic disease
Tuncay Aydın, Gülcan Özomay Baykal, Cüneyt Karagöl, Fatih Haşlak, Ebru Oğultekin Vazgeçer, Rüya Torun, Zehra Kızıldağ, Elif Kılıç Könte, Esma Aslan, Vildan Güngörer, Banu Çelikel Acar, Betül Sözeri, Özgür Kasapçopur, Balahan Makay
DOI: 10.46497/ArchRheumatol.2024.10356
Pandemic of the century: COVID-19 in inflammatory rheumatic diseases of a national cohort with 3,532 patients
Fatma Yurdakul, Hatice Bodur, Ahmet Kıvanç Cengiz, Yunus Durmaz, Mehmet Tuncay Duruöz, Taciser Kaya, Sertaç Ketenci, Nihan Cüzdan, Tuba Güler, Zafer Günendi, Selda Sarıkaya, Erhan Çapkın, Mustafa Erkut Önder, Meltem Alkan Melikoğlu, Rengin Güzel, Nesrin Şen, Ata Bora Ayna, Özgür Akgül, Erhan Eser, Şebnem Ataman
DOI: 10.46497/ArchRheumatol.2024.10313